Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hossann

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Contrast Media & Molecular Imaging|March 12, 2008
In vitro characterization of phosphatidylglyceroglycerol-based thermosensitive liposomes with encapsulated 1H MR T1-shortening gadodiamideTungte Wang, Martin Hossann, Herbert M Reinl, et al.
Investigative Radiology|November 13, 2008
MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumorsMichael Peller, Alenka Schwerdt, Martin Hossann, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 27, 2017
Impact of plasma protein binding on cargo release by thermosensitive liposomes probed by fluorescence correlation spectroscopyJudith J Mittag, Barbara Kneidl, Tobias Preiβ, et al.
Trends in Molecular Medicine|March 6, 2014
Nanomedicine-based strategies for treatment of atherosclerosisMaximilian Schiener, Martin Hossann, Joana R Viola, et al.
Biochimica Et Biophysica Acta. Biomembranes|July 20, 2021
Evaluation of release and pharmacokinetics of hexadecylphosphocholine (miltefosine) in phosphatidyldiglycerol-based thermosensitive liposomesAlexander Rysin, Michael Paal, Wouter J M Lokerse, et al.
Journal of Pharmaceutical Sciences|April 8, 2023
Heat-Triggered Release of Dexamethasone from Thermosensitive Liposomes Using Prodrugs or ExcipientsAlexander Rysin, Wouter J M Lokerse, Michael Paal, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 28, 2021
DPPG<sub>2</sub>-based thermosensitive liposomes as drug delivery system for effective muscle-invasive bladder cancer treatment <i>in vivo</i>Iris S G Brummelhuis, Michiel Simons, Lars H Lindner, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 19, 2012
Non-ionic Gd-based MRI contrast agents are optimal for encapsulation into phosphatidyldiglycerol-based thermosensitive liposomesMartin Hossann, Tungte Wang, Zulfiya Syunyaeva, et al.
Pharmaceutical Research|March 7, 2014
Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomesSimone Limmer, Jasmin Hahn, Rebecca Schmidt, et al.
Protein Expression and Purification|October 19, 2005
Novel immunotoxin: a fusion protein consisting of gelonin and an acetylcholine receptor fragment as a potential immunotherapeutic agent for the treatment of Myasthenia gravisMartin Hossann, Zhuoyu Li, Yawei Shi, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Contrast Media & Molecular Imaging|March 12, 2008
In vitro characterization of phosphatidylglyceroglycerol-based thermosensitive liposomes with encapsulated 1H MR T1-shortening gadodiamideTungte Wang, Martin Hossann, Herbert M Reinl, et al.
Investigative Radiology|November 13, 2008
MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumorsMichael Peller, Alenka Schwerdt, Martin Hossann, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 27, 2017
Impact of plasma protein binding on cargo release by thermosensitive liposomes probed by fluorescence correlation spectroscopyJudith J Mittag, Barbara Kneidl, Tobias Preiβ, et al.
Trends in Molecular Medicine|March 6, 2014
Nanomedicine-based strategies for treatment of atherosclerosisMaximilian Schiener, Martin Hossann, Joana R Viola, et al.
Biochimica Et Biophysica Acta. Biomembranes|July 20, 2021
Evaluation of release and pharmacokinetics of hexadecylphosphocholine (miltefosine) in phosphatidyldiglycerol-based thermosensitive liposomesAlexander Rysin, Michael Paal, Wouter J M Lokerse, et al.
Journal of Pharmaceutical Sciences|April 8, 2023
Heat-Triggered Release of Dexamethasone from Thermosensitive Liposomes Using Prodrugs or ExcipientsAlexander Rysin, Wouter J M Lokerse, Michael Paal, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 28, 2021
DPPG<sub>2</sub>-based thermosensitive liposomes as drug delivery system for effective muscle-invasive bladder cancer treatment <i>in vivo</i>Iris S G Brummelhuis, Michiel Simons, Lars H Lindner, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 19, 2012
Non-ionic Gd-based MRI contrast agents are optimal for encapsulation into phosphatidyldiglycerol-based thermosensitive liposomesMartin Hossann, Tungte Wang, Zulfiya Syunyaeva, et al.
Pharmaceutical Research|March 7, 2014
Gemcitabine treatment of rat soft tissue sarcoma with phosphatidyldiglycerol-based thermosensitive liposomesSimone Limmer, Jasmin Hahn, Rebecca Schmidt, et al.
Protein Expression and Purification|October 19, 2005
Novel immunotoxin: a fusion protein consisting of gelonin and an acetylcholine receptor fragment as a potential immunotherapeutic agent for the treatment of Myasthenia gravisMartin Hossann, Zhuoyu Li, Yawei Shi, et al.
Pageof 3